Joseph Vazzano
Directeur Financier/CFO chez ABEONA THERAPEUTICS INC.
Fortune : 1 M $ au 31/05/2024
Profil
Joseph Vazzano is an Independent Director at Allarity Therapeutics A.
He is also an Independent Director at Allarity Therapeutics, Inc. and the Chief Financial & Accounting Officer at Abeona Therapeutics, Inc. Mr. Vazzano previously worked as an Assistant Corporate Controller at Intercept Pharmaceuticals, Inc. and as a Senior Auditor at KPMG LLP.
He also served as an Assistant Controller at Pernix Therapeutics, Inc. and as the Chief Financial Officer & Secretary at Avenue Therapeutics, Inc. Mr. Vazzano obtained his undergraduate degree from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/04/2024 | 233 868 ( 0,57% ) | 1 M $ | 31/05/2024 |
Postes actifs de Joseph Vazzano
| Sociétés | Poste | Début |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur Financier/CFO | 14/03/2022 |
| ALLARITY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2023 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Directeur/Membre du Conseil | - |
Anciens postes connus de Joseph Vazzano
| Sociétés | Poste | Fin |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Directeur Financier/CFO | 07/01/2022 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2017 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| Pernix Therapeutics, Inc. | Corporate Officer/Principal | - |
Formation de Joseph Vazzano
| Lehigh University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
| Pernix Therapeutics, Inc. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
